| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Kuebler Christopher A is a Director at NEKTAR THERAPEUTICS with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $9.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2017 | WAT Waters Corp /de/ | Director | Sale+OE | 3,500 | $179.67 | $628,845.00 | -19.6% | |
| Apr 5, 2017 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $21.88 | $328,200.00 | -29.7% | |
| Sep 16, 2016 | NKTR Nektar Therapeutics | Director | Sale+OE | 7,500 | $19.13 | $143,475.00 | -21.4% | |
| May 4, 2016 | WAT Waters Corp /de/ | Director | Sale+OE | 4,000 | $129.88 | $519,520.00 | -19.5% | |
| Dec 4, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $15.82 | $237,300.00 | -42.9% | |
| Nov 23, 2015 | WAT Waters Corp /de/ | Director | Sale+OE | 4,000 | $133.17 | $532,680.00 | -24.0% | |
| Jan 13, 2015 | NKTR Nektar Therapeutics | Director | Sale+OE | 15,000 | $16.00 | $240,000.00 | -42.9% |